Condition: Upper Limb Spasticity · Sponsor: Chongqing Claruvis Pharmaceutical Co., Ltd.
This is an open-label, multicenter, phase III clinical study to evaluate the long-term safety and efficacy of multiple treatments with recombinant botulinum toxin type A (YY001) for injection in adult upper limb spasticity
This description comes directly from the study's public registry record.
Jieru Bai · +86 13883955310 · bai.jieru@claruvis.com
Xiaoyun Sun · sun.xiaoyun@claruvis.com
Always discuss trial participation with your own doctor first.
| Peking Union Medical College Hospital | Beijing, China | Recruiting |
| West China Hospital，Sichuan University | Chengdu, China | Recruiting |
| Guangdong Provincial People's Hospital | Guangdong, China | Recruiting |
| Sun Yat-sen Memorial Hospital | Guangzhou, China | Recruiting |
| The Second People's Hospital of Hefei | Hefei, China | Recruiting |
| Huai'an First Hospital Affiliated to Nanjing Medical University | Huai'an, China | Recruiting |
| The First Affiliated Hospital of Henan University | Kaifeng, China | Recruiting |
| The Second Affiliated Hospital of Kunming Medical University | Kunming, China | Recruiting |
| Shanghai Fudan University HuaShan Hospital | Shanghai, China | Recruiting |
| Yangzhi Affiliated Rehabilitation Hospital of Tongji University | Shanghai, China | Recruiting |
| Shenzhen Second People's Hospital | Shenzhen, China | Recruiting |
| The First Affiliated Hospital of Soochow University | Suzhou, China | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07478822